Boston Scientific, Covidien get in on SetPoint Medical’s $27M round August 8, 2013 By Brad Perriello Leave a Comment SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.